Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Butabarbital sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for butabarbital sodium and what is the scope of butabarbital sodium patent protection?

Butabarbital sodium
is the generic ingredient in ten branded drugs marketed by Solvay, Hikma Pharms Llc, Halsey, Marshall Pharma, Whiteworth Town Plsn, Teva, Sandoz, Ivax Sub Teva Pharms, Lannett, Bundy, Watson Labs, Alpharma Us Pharms, Meda Pharms, Medpointe Pharm Hlc, Wockhardt, and Mylan Speciality Lp, and is included in thirty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for butabarbital sodium. One supplier is listed for this compound.

Summary for Generic Name: butabarbital sodium

Drug Master File Entries: see list9
Suppliers / Packagers: see list1
Bulk Api Vendors: see list23
Clinical Trials: see list923
Patent Applications: see list2,862
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:butabarbital sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
butabarbital sodium
TABLET;ORAL085772-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
butabarbital sodium
ELIXIR;ORAL085880-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
butabarbital sodium
TABLET;ORAL088631-001May 1, 1985DISCNNoNo► Subscribe► Subscribe
Marshall Pharma
butabarbital sodium
TABLET;ORAL083524-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
butabarbital sodium
TABLET;ORAL085934-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus